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Background: The postnatal period is a critical time window during which inflammatory events have significant and
enduring effects on the brain, and as a consequence, induce alterations of emotional behavior and/or cognition
later in life. However, the long-term effect of neonatal inflammation on behavior during adolescence, a sensitive period
for the development of neurodevelopmental psychiatric disorders, has been little studied. In this study, we examined
whether an early-life inflammatory challenge could alter emotional behaviors and spatial memory at adolescence and
adulthood and whether stress axis activity, inflammatory response and neurogenesis were affected.
Methods: Lipopolysaccharide (LPS, 100 μg/kg) was administered to mice on postnatal day (PND) 14 and cytokine
expression was measured in the plasma and in brain structures 3 hours later. Anxiety-like and depressive-like behavior
(measured in the novelty-suppressed feeding test and the forced swim test, respectively) and spatial memory
(Y-maze test) were measured at adolescence (PND30) and adulthood (PND90). Hypothalamic-pituitary-adrenal
(HPA) axis activity (plasma corticosterone and glucocorticoid receptors in the hippocampus and prefrontal cortex)
was measured at adulthood. In addition, the impact of a novel adult LPS challenge (100 μ/kg) was measured on
spatial memory (Y-maze test), neurogenesis (doublecortin-positive cell numbers in the hippocampus) and plasma
cytokine expression.
Results: First, we show in PND14 pups that a peripheral administration of LPS induced the expression of pro- and
anti-inflammatory cytokines in the plasma and brain structures that were studied 3 hours after administration.
Anxiety-like behavior was altered in adolescent, but not in adult, mice, whereas depressive-like behavior was
spared at adolescence and increased at adulthood. This was accompanied by a decreased phosphorylation of the
glucocorticoid receptor in the prefrontal cortex, with no effect on corticosterone levels. Second, neonatal LPS
treatment had no effect on spatial memory in adolescence and adulthood. However, a second challenge of LPS in
adulthood impaired spatial memory performance and neurogenesis and increased circulating levels of CCL2.
Conclusions: Our study shows for the first time, in mice, that a peripheral LPS treatment at PND14 differentially
alters emotional behaviors, but not spatial memory, at adolescence and adulthood. The behavioral effect of LPS at
PND14 could be attributed to HPA axis deregulation and neurogenesis impairment.
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According to the concept of perinatal programming of
adult behavior [1], the postnatal period is a critical time-
window during which an adverse event can have signifi-
cant and enduring effects on the development of the cen-
tral nervous system, and as a consequence, on behavior
later in life. In this context, an inflammatory event during
brain development has been shown to strongly increase
the risk for the development of psychiatric disorders such
as autism or schizophrenia [2,3].
In rodents, the early-life exposure to lipopolysaccharide
(LPS), a Gram-negative bacteria endotoxin that induces
inflammatory response, increases the risk of developing
emotional behavior [4,5] as well as cognitive [6] alterations
at adulthood. In neonate rodents, immune challenge has
been reported to stimulate the production of proinflam-
matory cytokines, such as interleukin(IL)-1β, IL-6 and
tumor necrosis alpha (TNFα), both at the periphery and
in the brain [7], together with enhanced corticosterone
levels [8]. These factors have been proposed to adversely
impacts fetal brain development [9,10] such as hippocam-
pal neurogenesis [11]. Studies in rodents have shown that
postnatal day (PND)14 is a crucial period for brain net-
work maturation. Microglial cells actively engulf synaptic
material and play a major role in synaptic pruning during
postnatal development in mice [12]. This synaptic pruning
is particularly efficient at PND14, and alteration in micro-
glia function induced by an inflammatory event at this
period may contribute to synaptic abnormalities seen in
some neurodevelopmental disorders [13]. Moreover at
PND14, the neonatal stress axis is no longer in a hypo-
responsive state [14], and pups exhibit an enhanced re-
sponse of adrenocorticotropic hormone (ACTH) and
corticosterone to LPS [15] that could also contribute to
altered brain development.
The disruption of brain development linked to inflam-
matory factors exposure can exert a marked deficit in
neuroimmune response and HPA axis activity at adult-
hood. In rats, exposure to LPS in early life increases
corticotrophin-releasing hormone (CRH) mRNA levels
in the hypothalamus; decreases glucocorticoid receptor
(GRs) density in the hypothalamus, hippocampus and
frontal cortex [16]; and increases HPA responsiveness to
stress at adulthood [16,17]. Hypothalamic cyclooxygen-
ase(COX)-2 expression induced by LPS administration
in adulthood was attenuated in neonatally LPS-treated
rats [18]. Some authors proposed that the long-lasting
impact of an early-life immune challenge on the neu-
roimmune response at adulthood is strongly linked to
the heightened HPA responsiveness [19,20]. Addition-
ally, it has been shown that neonatal immune chal-
lenges impact memory and cognitive ability in adults
[21-24]. Neonatal LPS in rats leads to memory deficits
in adulthood only if unmasked by a subsequent LPStreatment 24 h before learning or immediately after
learning [8,23,25-27].
Adolescence is a period of neurobehavioral shaping
during which the hippocampus, amygdala and prefrontal
cortex undergo maturation [28]. During this develop-
mental period, synaptic pruning, as well as myelination,
increases in order to refine functional connectivity [29].
This dynamic process strengthens network cohesion and
contributes to developmental changes in patterns of brain
activation [30]. As a consequence, neurobiological changes
induced by neonatal inflammation can be particularly
problematic at adolescence [29]. A recent work reveals
that LPS administration during the pre- and postnatal
periods alters behavior in adolescent rats [31]. Despite
strong evidences that neonatal exposure to infection has
a significant influence on adult behavioral outcomes
[32], the period of sensitivity to early-life immune acti-
vation at PND14 and the short-term and long-term be-
havioral consequences remain relatively unexplored,
particularly at adolescence. Overall, more research is
needed to explore the longitudinal effect of PND14
neonatal LPS administration on emotional behavior and
memory and the mechanisms through which an early-life
immune challenge leaves a permanent change in the de-
veloping brain, on the inflammatory system, and on HPA
axis activity in particular.
In the current study on mice, we evaluated whether an
exposure to LPS in neonatal life (here PND14) 1) alters
emotional behavior and spatial memory at adolescence
and adulthood; 2) is associated with HPA axis dysfunc-
tions at adulthood as manifested by alterations in cortico-
sterone and glucocorticoid receptors (GR) expression in
the brain; and 3) alters memory, neurogenesis and inflam-




All experiments were conducted according to the
INRA Quality Reference System and to relevant French
(Directive 87/148, Ministère de l’Agriculture et de la Pêche)
and European (Directive 86/609, November 24th 1986,
European Community) legislation. They followed ethical
protocols approved by the Région Aquitaine Veterinary
Services (Direction Départementale de la Protection des
Animaux, approval ID: A33-063-920) and by the ethics
committee of animal experimentation of Bordeaux (seisin
N° 50120112-A). Every effort was made to minimize suf-
fering and the number of animals used.
Unmated adult male and female swiss mice (CD-1 mice)
were obtained from Janvier (St Berthevin, France). They
were housed in same sex pairs in polypropylene cages
and maintained in a temperature- and humidity-controlled
pathogen-free facility on a 12 h light-dark cycle with ad
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At P4, litters were harmonized at 12 pups/litter with as
many males as possible and a minimum of 3 females. All
studies were limited to males. Male pups were injected
at PND14 [33] with LPS (E.coli, serotype 0127:B8, Sigma
Aldrich (Lyon, France), dissolved in sterile endotoxin-
free isotonic saline, 100 μg/kg, intraperitoneally (i.p.)).
Endotoxin-free isotonic saline was used as the vehicle
control. Each litter was balanced in LPS and control
pups.
Three cohorts of mice were used (Figure 1). Cohort 1
was used to evaluate the effect of an LPS administration
on brain cytokine production in the brain of PND14
mice pups. CD1 mice pups (PND14) (n = 20) received an
injection of LPS and were sacrificed 3 h later. Plasma
and brain structures (hippocampus, hypothalamus, pre-
frontal cortex and amygdala) were collected. Then, pro-
and anti-inflammatory cytokine expression was measured
by BioPlex in the plasma and by real time-PCR in brain
structures.
Cohort 2 (n = 40) was used to evaluate the impact of neo-
natal LPS administration on emotional behavior and spatial
memory at adolescence (PND30) and adulthood (PND90).Figure 1 Schematic timeline of the study design and experimental prIn the first subgroup, PND30 mice were submitted to
NFST and 1 week later to FST. Then, at PND90, mice
were submitted to the same behavioral testing. In a sec-
ond subgroup of mice, spatial memory was measured at
adolescence (PND30) and at adulthood (PND90) using
the Y-maze test in the same mice. All mice were sacrificed
24 h after the last behavioral test at PND90 to evaluate
HPA axis activity and neurotrophin expression. After sac-
rifice, brain structures (hippocampus and prefrontal cor-
tex) and plasma were collected. Expression of GR and its
phosphorylated form, BDNF and its receptor trkB were
measured by western blot from various brain structures
and corticosterone levels were determined by radio-
immunoassay (RIA) from the plasma.
Cohort 3 (n = 31) was used to evaluate the effect of a
second hit of LPS administrated at adulthood on spatial
memory, neurogenesis and cytokine production in the
plasma. For this purpose, LPS-treated mice at PND14
and their controls were submitted to a LPS treatment
(i.p., 100 μg/kg) at adulthood (PND90). Then, 24 h after
administration of the second LPS treatment, spatial mem-
ory was assessed in the Y-maze test, and mice were sacri-
ficed 2 h later. Brain and plasma were collected. Cytokinesotocols.
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and doublecortin (DCX) immunohistochemistry was per-
formed in the dentate gyrus of the hippocampus.
Behavioral testing
Novelty-suppressed feeding test
The novelty-suppressed feeding test (NSFT) paradigm is
a conflict test that elicits competing motivations between
the drive to eat and the fear of venturing into the center
of brightly lit arena. Latency to begin eating is used as
an index of anxiety-like behavior because classical anxio-
lytic drugs as well as chronic treatment with selective
serotonin reuptake inhibitor decrease this index [34].
Mice were food-deprived for 24 h prior to the test. Test-
ing was performed in a 50 × 50 cm box covered with
bedding and illuminated by a 70-watt lamp. The latency
to eat pellets of food placed on the top of a piece of
white filter paper in the center of the box was measured.
Each mouse was tested individually for 5 min [34]. Two
different arenas were used at P30 and at P90 to avoid
potential interferences.
Forced swim test
The standardized forced swim test (FST) of depressive-
like behavior was conducted as previously described
[35,36]. Briefly, each mouse was placed individually in a
cylinder (16 × 31 cm) containing warm water (25 ± 1°C)
to avoid temperature-related stress response. Mice were
tested during a 6-min period. Immobility time was assessed
by measuring the time a mouse stopped swimming and
moved only slowly to remain floating in the water, keeping
its head above the water surface. Increased duration of im-
mobility has been proposed to reflect a state of helpless-
ness that is reduced by antidepressants.
Y-maze
Spontaneous spatial recognition in the Y-maze was used
as a hippocampal-dependent test as previously described
[36,37]. The apparatus consisted in a Y-shaped acrylic
maze with three identical arms (34 × 8 × 14 cm). The
floor was covered with corncob litter and was mixed be-
tween each trial in order to remove olfactory cues. Visual
cues were placed on the walls of the testing room and kept
constant during the whole test. Discrimination of novelty
versus familiarity was based on the various environmental
cues that the mouse can perceive from each arm of the
Y-maze. In the first trial of the test (acquisition), one
arm was closed with a door and mice were allowed to
freely visit the two other arms for 5 min. After a 30-min
intertrial interval (ITI), mice were again placed in the
‘start’ arm for the second trial (retrieval) and allowed
free access to all three arms for 5 min. ‘Start’ and closed
arms were randomly assigned to each mouse. Arm entries
were defined as all four paws entering the arm. Preferencefor novelty was also measured using a short 2-min ITI be-
tween acquisition and retrieval in order to control for po-
tential motivational disturbances [36,37]. Analyses were
based on the time spent exploring the novel and the famil-
iar arms during the 5 min of the second trial.
Biochemical/histological measurements
Immunohistochemical detection of doublecortin -positive
cells
After transcardiac perfusion with phosphate buffered saline
(PBS, pH 7.4), followed by 4% paraformaldehyde (PFA),
brains were removed, postfixed for 4 h in PFA, cryopro-
tected in 30% sucrose for 24 h, snap frozen in liquid nitro-
gen, and stored at -80°C before sectioning. Free-floating
(30 μm) coronal sections containing the hippocampus
(from -0.9 mm to -3.1 mm relative to bregma) were col-
lected on a cryostat for immunohistochemistry.
Neurogenesis in the hippocampus was evaluated by
determining the number of immature neurons in the
dentate gyrus characterized by the endogenous marker
doublecortin (DCX) (Santa Cruz Biotechnology, CA, USA),
a cytoplasmic protein expressed transiently in newborn
neurons only [38,39]. Briefly, 30-μm sections were incu-
bated with rabbit anti-DCX antibody (1:800; Abcam,
Cambridge, UK) followed by a biotinylated secondary
antibody and streptavidin peroxidase complex, which was
visualized by diaminobenzidine-nickel staining. The num-
ber of DCX positive cells was counted on three sections
representing the same three levels of the dentate gyrus for
all animals [39].
Measurement of neurotrophins, neurotrophin receptor and
glucocorticoid receptors by western blot
Western blot analyses of the neurotrophic factor BDNF
and its receptor TrkB and glucocorticoid receptor (GR)
and its phosphorylated form (P-GR) were performed ac-
cording to a previously published method [40]. Briefly,
the hippocampus and prefrontal cortex were homoge-
nized with a Precellys 24 system (Bertin Technologies,
Aix en Provence, France) in lysis buffer (20 mM Tris,
pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.5 M EDTA,2 mM
sodium orthovanadate (Na3VO4), and 1 mM NaF) con-
taining protease inhibitor cocktail (Sigma, Saint-Louis,
MO, USA). After centrifugation, protein concentration
was determined using a BCA assay kit (Uptima, Montlucon,
France). Equal amount of proteins (50 μg) were loaded
onto SDS-PAGE gels (10% acrylamide) and transferred onto
polyvinylidene difluoride (PVDF) membranes (Millipore,
Billerico, MA, USA). Membranes were incubated over-
night at 4°C with the following primary antibodies: anti-
glucocorticoid receptor (GR) (M-20) (1:2000, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-phospho-
GR (Ser211) and anti-TrkB (80E3) (1:1000; Cell Signaling
Technology, Boston, MA, USA), anti-BDNF (1:1000;
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St-Louis, MO, USA). After being washed, membranes were
incubated with peroxidase-conjugated secondary anti-
rabbit antibody for 1 h (1:5000; Jackson ImmunoResearch
laboratories, Westgrove, PA, USA). Between successive
probing with antibodies, membranes were incubated for
15 min in stripping buffer (ReBlot Plus Strong Antibody
Stripping Solution, Millipore) in order to remove the pre-
vious antibody. Staining was revealed with the ECL-Plus
Western blotting detection system (Perkin Elmer, Forest
City, CA, USA) or Lumina Forte Western HRP substrate
(Millipore, Billerico, MA, USA). Chemiluminescence was
captured by a Syngene detection system and quantified by
Gene Tools software (Syngene, Cambridge, UK).
Assessment of corticosterone by radioimmunoassay
Total plasma corticosterone (CORT) was measured by
an in-house radioimmunoassay (RIA, for details, see Ref.
[41]). Briefly, after steroid extraction of plasma samples
with absolute ethanol, total CORT was measured by
competition between cold CORT and 3H-CORT by a
specific anti-CORT antibody provided by H. Vaudry
(University of Rouen, Rouen, France).
Assessment of cytokine and chemokine by BioPlex
Blood samples from mice were collected in EDTA-coated
vials and centrifuged for 15 min at 3,000 g at 4°C, ali-
quoted and stored at -80°C. Milliplex map kits were used
for all assays (Millipore, Molsheim, France) as previously
described [36]. All samples were run in duplicate and were
assayed for IL-1β, IL-6, TNF-α, IFN-γ, IL-10 at PND 14
and IL-1β, IL-6, TNF-α, IFN-γ, IL-10 and CCL2 at adult-
hood according to the manufacturer's instructions. Results
were expressed in pg/ml. Minimum detectable concentra-
tion was 5.4, 1.1, 2.3, 1.1, 2.0 and 6.7 pg/ml, respectively.
Reverse transcription and real-time RT-PCR
Mice were sacrificed by cardiac puncture after isoflurane
anesthesia and were transcardially perfused with PBS.
Brain structures were quickly removed and frozen on
dry ice. Two micrograms of total RNA were obtained
from each brain area were reverse transcribed with
SuperScript III reverse transcriptase (Invitrogen, Cergy-
Pontoise, France). Quantitative PCR was then performed
using the Applied Biosystems Assay-on- Demand Gene
Expression Products protocol, as previously described
[36,42]. Briefly, cDNAs for IL-6, IL-1β, TNF-α, IFNγ,
IL-10 and a housekeeping gene (β2-microglobulin) were
amplified by PCR using an oligonucleotide probe with a
5’ fluorescent reporter dye (6-FAM) and a 3’ quencher
dye (NFQ). Fluorescence was measured using an AB
7500 Real-Time PCR system (Applied Biosystems, Foster
city, CA), and final quantification was carried out using
the comparative threshold (Ct) method as previouslydescribed [36,42]. For each experimental sample, differ-
ence between target gene and housekeeping gene Ct
values (ΔCt) was used to normalize for differences in
the amount of total nucleic acid added to each reaction
and in the efficiency of the reverse transcription step.
Values were then expressed as relative fold change
(RFC) of the mean ΔCt value obtained for the group of
control mice (calibrator ΔCt) by subtracting ΔCt for each
experimental sample from the calibrator ΔCt ( = ΔΔCt)
The amount of target gene (linear value) normalized to
the housekeeping gene and relative to the calibrator was
determined by 2 −ΔΔCt.
Statistical analysis
All data are expressed as the mean ± SEM. Behavioral
and biochemical data were statistically analyzed using com-
parisons between saline and LPS-treated mice at PND14
using an unpaired Student’s t-tests. A P value <0.05
was considered as significant. Data obtained after a second
LPS stimulus were analyzed using a two-way ANOVA test
with treatment at PND14 (saline versus LPS) and treat-
ment at adulthood (saline versus LPS) as between fac-
tors, followed by Bonferroni post-hoc comparisons when
appropriate.
Results
Lipopolysaccharide administration to postnatal day 14
mice induces the mRNA expression of pro- and
anti-inflammatory cytokine in the brain
We first investigated the effect of LPS injection (100 μg/kg)
at PND14 on plasmatic cytokine production. As expected,
LPS treatment induced a significant increase in plasma
levels of IL-6 (t(17) = 3.290, P <0.01), TNF-α (t(19) = 4.492,
P <0.001), IL-1β (t(18) = 2.627, P <0.05) and IL-10 (t(19) =
5.341, P <0.001) 3 hours later (Figure 2A).
We also measured cytokine mRNA expression 3 h
postinjection in the hippocampus, hypothalamus, prefrontal
cortex and amygdala (Figure 2B,C,D and E). LPS-induced
IL-6 mRNA expression was significantly increased in
the hypothalamus (t(19) = 2.229, P <0.05), prefrontal
cortex (t(20) = 3.289, P <0.01) and amygdala (t(19) =
4.691, P <0.001). IL-1β and TNF-α expression was sig-
nificantly increased in the hippocampus (t(20) = 3.890,
P <0.001 and t(20) = 5.078, P <0.001, respectively),
hypothalamus (t(18) = 2.338, P <0.05 and t(18) = 4.572,
P <0.001, respectively), prefrontal cortex (t(19) = 3.130,
P <0.01 and t(20) = 4.640, P <0.001, respectively) and amyg-
dala (t(19) = 4.981, P <0.001 and t(19) = 4.691, P <0.001,
respectively) 3 h after a LPS treatment. IL-10 mRNA ex-
pression was increased only in the hypothalamus and
hippocampus (t(20) = 2.360, P <0.05 and t(20) = 2.3600,
P <0.05 respectively) of LPS-treated mice, but there was












































































































































































































































































































































Figure 2 Lipopolysaccharide (LPS) increases cytokines expression in plasma and brain structures of postnatal day 14 (PND14) mice.
Plasma concentration (pg/ml) of cytokines was measured by BioPlex 3 h after intraperitoneal (i.p.) administration of saline or LPS (100 μg/kg) in
mice (A). Cytokine mRNA expression was measured by real-time rt-PCR in the hypothalamus (B), hippocampus (C), prefrontal cortex (D) and
amygdala (E). Data are expressed as mean ± SEM, *P < .05, **P < .01, ***P < .001, for NaCl compared to LPS, n = 20.
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emotional behavior of adolescent and adult mice
Anxiety-like behavior of LPS-treated PND14 mice was
measured in NSFT at adolescence (PND30) and adult-
hood (PND90). At PND30, the time for saline-treatedmice to reach and start eating the food pellet in the cen-
ter of the arena was significantly shorter as compared to
the LPS-treated mice (P <0.05, t = 2.404) (Figure 3, top
left panel). No significant difference in the latency to
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Figure 3 Postnatal day 14 (PND14) neonatal lipopolysaccharide (LPS) differentially alters anxiety-like behavior, depressive-like behavior
and spatial memory at adolescence (PND30) and adulthood (PND90). Anxiety-like behavior was evaluated in the novelty-suppressed feeding
test (NSFT) by measuring the latency (sec) of first food consumption in the center of the arena (n = 20). Depressive-like behavior was evaluated in
the forced swim test (FST) by measuring the swimming occurrence (number) during 5 min (n = 20). Data are expressed as mean ± SEM. P <0.05.
Spatial memory was evaluated in the Y-maze test by measuring the time spent exploring the novel and the familiar arms over a 5-min test and
after a 30-min retention delay (n = 20). Data are expressed as mean ± SEM. *P <0.05, ***P <0.001, for familiar arm compared to novel arm.
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Even if neonatal LPS-treated mice slightly gained more
weight than controls throughout life, no significant dif-
ference in weight loss was measured after fasting (data
not shown), suggesting that the longer latency to eat the
pellet is not related to a change in hunger in the LPS-
treated animals.
At PND30, the measurement of swimming occur-
rences in the FST revealed no significant differences
between groups (Figure 3, middle left panel). In con-
trast, LPS-treated PND14 mice presented a decreased
number of swimming occurrences at PND90 compared
to control mice (P <0.05, t = 2.749) (Figure 3, middle
right panel).
No significant effect of the LPS treatment at PND14
was revealed on spatial memory performance measured
at adolescence (PND30) or adulthood (PND90) in theY-maze test with an ITI of 30 min (Figure 3, bottom
panels left and right).
Lipopolysaccharide treatment at postnatal day 14 alters
glucocorticoid receptor phosphorylation in the prefrontal
cortex of adult mice
Since emotional behavior is altered in adult mice treated
with LPS at PND14, we next assessed the integrity of
the stress system in brain structures involved in emo-
tional behavior. Total GR and its phosphorylated form
(PGR) were measured by western blot in the prefrontal
cortex (Figure 4A) and the hippocampus (Figure 4B) of
adult mice treated with LPS at PND14. No significant
difference was detected for GR expression in the pre-
frontal cortex or the hippocampus. The PGR/GR ratio
was significantly decreased in the prefrontal cortex (P <0.05,
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Figure 4 Postnatal day 14 (PND14) neonatal lipopolysaccharide (LPS) decreases the phosphorylated glucocorticoid receptor/
glucocorticoid receptor ratio in the prefrontal cortex at adulthood. Representative immunoblots corresponding to the phosphorylated
form of glucocorticoid receptor (PGR) and total glucocorticoid receptor (GR) in the prefrontal cortex (A) and the hippocampus (B) of adult mice
receiving either NaCl or LPS at PND14 are presented. Immunoblots were quantified and the ratios for PGR/GR (left graph panels) or GR/actin
were calculated (right graph panels). Data are expressed as mean ± SEM (n = 10/group). *P <0.05, for NaCl compared to LPS. Plasma corticosterone
levels were measured by radioimmunoassay (RIA) in the plasma (C). Data are expressed as mean ± SEM (n = 10/group). *P <0.05, for NaCl
compared to LPS.
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ation in the prefrontal cortex structure. Plasma cor-
ticosterone was not altered by PND14 LPS injection
(Figure 5C). BDNF, TrkB and actin protein levels
were measured in the hippocampus and the prefrontal
cortex of adult mice by western blot. Expression of BDNF
and its receptor TrkB was not impaired by LPS adminis-
tered at PND14 (data not shown).
Lipopolysaccharide treatment at adulthood impairs spatial
memory performance in lipopolysaccharide-treated
postnatal day 14 mice
We then evaluated the effect of a second LPS adminis-
tration at adulthood on spatial memory (Figure 5). At
adulthood, NaCl or LPS-treated mice at PND14 re-
ceived an i.p. administration of NaCl (NaCl-NaCl and
LPS-NaCl) or LPS (NaCl-LPS and LPS-LPS) and spatial
memory was assessed using a Y-maze test 24 h later.
Spatial memory differed across the treatments since only
mice subjected to a double-hit of LPS spent the same time
exploring the familiar arm and the novel arm (NaCl-NaCl,P <0.05, NaCl-LPS, P <0.05, LPS-NaCl, P <0.01, LPS-LPS,
P = 0.166) (Figure 5). Total locomotion was not affected
by the LPS treatment (data not shown).
Lipopolysaccharide treatment at adulthood decreases the
number of doublecortin-positive cells in the dentate
gyrus of the hippocampus of lipopolysaccharide-treated
postnatal day 14 mice
Immature DCX-expressing neurons play an important
role in spatial memory, particularly in learning [39,43].
We next assessed whether the memory impairment in-
duced by the LPS-LPS treatment was accompanied by an
alteration in the number of DCX-positive cells in the den-
tate gyrus. No significant effect of a single LPS administra-
tion either at PND14 or at adulthood was detected on the
number of DCX-positive cells in the dentate gyrus of the
hippocampus of adult mice. However, a second exposure
to LPS at adulthood primed by an injection of LPS at
PND14 resulted in a significant decrease in the number of
DCX-positive cells (-25%) as compared to saline-treated







































Figure 5 A lipopolysaccharide (LPS) challenge at adulthood impairs spatial memory in postnatal day 14 (PND14) neonatal LPS mice.
Spatial memory performance was evaluated in the Y-maze test by measuring the time spent exploring the novel and the familiar arms. Measures
were performed 24 h after intraperitoneal (i.p.) administration of saline or lipopolysaccharide (LPS, 100 μg/kg) in adult mice. They were assessed
over a 5-min test and after a 30-min retention intertrial interval (ITI). Data are expressed as means ± SEM (n = 15/group). *P <0.05, **P <0.01, for
familiar arm compared to novel arm.
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CCL2 in the plasma of lipopolysaccharide-treated
postnatal day 14 mice
In adult animals, hippocampal neurogenesis participates
in hippocampal-dependent memory [44] and is influenced
by proinflammatory cytokines and chemokines, such as
CCL2 [45,46]. We then asked whether the priming ef-
fect of PND14 LPS administration on LPS injection in
adulthood could be related to an alteration in the*
Figure 6 A lipopolysaccharide (LPS) challenge at adulthood
reduces the number of doublecortin (DCX)-positive cells in the
dentate gyrus of the hippocampus of postnatal day 14 (PND14)
neonatal LPS mice. Neurogenesis was evaluated by quantifying the
number of DCX-positive cells in the dentate gyrus of the hippocampus.
Data are expressed as means ± SEM (n = 8/group). *P <0.05, for the
NaCl-NaCl group compared to the LPS-LPS group.sensitivity of the immune system response. Cytokines
(IL-6, IL-1β, TNF-α, IFN-γ and IL-10) and CCL2 (che-
mokine C-C motif ligand 2, also called MCP-1) were
measured in the plasma 24 h after the second injection
of LPS at adulthood.
No significant effect of LPS on plasmatic cytokine
levels was revealed (data not shown). Of importance,
CCL2 was significantly increased in the blood of mice
treated with LPS at PND14 and at adulthood (LPS-LPS)
compared to saline-treated mice (LPS-NaCl) (P = 0.05)
(Figure 7).*
Figure 7 A lipopolysaccharide (LPS) challenge at adulthood
increases CCL2 in the plasma of postnatal day 14 (PND14)
neonatal LPS mice. CCL2 was measured in the plasma of adult
mice by BioPlex. Data are expressed as means ± SEM (n = 7/group).
*P = 0.05, for the NaCl-NaCl group compared to the LPS-LPS group.
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The present study demonstrates that a peripheral LPS
treatment at PND14, used to activate cytokine production
in the brain, induces an alteration of emotional behaviors
at adolescence (PND30) and adulthood (PND90). As a re-
sult, LPS-treated PND14 mice displayed altered anxiety-
like behavior measured in the NSFT at adolescence, but
not at adulthood. Of note, depressive-like behavior mea-
sured in the FST developed only at adulthood. This was
accompanied by a decreased phosphorylation of the GR re-
ceptor in the prefrontal cortex, with no effect on circulat-
ing corticosterone levels. Second, PND14-LPS treatment
had no effect on spatial memory measured in the Y-maze.
However, a second administration of LPS at adulthood im-
pairs spatial memory, DCX-positive cell numbers in the
dentate gyrus and CCL2 circulating levels suggesting that
LPS-treated PND14 mice were more vulnerable to LPS
treatment at adulthood compared to naïve mice.
Taken together, our study shows for the first time that,
in mice, a peripheral LPS treatment at PND14 differen-
tially alters anxiety-like and depressive-like behavior at
adolescence and adulthood. In adult mice, emotional be-
havior alteration is accompanied by a decreased phosphor-
ylation of the glucocorticoid receptor in the prefrontal
cortex. In addition, PND14,LPS treatment has no effect
on spatial memory. However, a second administration of
LPS at adulthood alters spatial memory, neurogenesis and
peripheral chemokine CCL2 levels.
In the current study, we first measured the expression
of pro- and anti-inflammatory cytokine expression in the
plasma, the prefrontal cortex, the hippocampus, the hypo-
thalamus and the amygdala of PND14 mice 3 h after LPS
treatment. As previously shown, a single injection of LPS
(100 μg/kg) in adult mice induced the expression of the
cytokines in the plasma and brain structures [47,48]. Our
results further revealed that at this dose, a single injection
of LPS at PND14 activated the expression of both pro-
(IL-6, TNF-α and IL-1β) and anti-inflammatory (IL-10)
cytokine mRNA expression in several brain structures.
However, the cytokine expression profile differed among
the brain structures investigated. IL-1β, IL-6, TNF-α and
IL-10 mRNA levels were significantly higher in the hypo-
thalamus and the hippocampus. However, whereas IL-1β,
IL-6 and TNF-α expression was induced in the amygdala
and the prefrontal cortex, IL-10 mRNA expression was
not. IL-10 is a potent anti-inflammatory cytokine [49].
In the brain, IL-1β and TNF-α expression is regulated by
IL-10 [50]. In addition, IL-10 suppresses TNF-α-induced
sickness behavior [51] and reverses the impairment in
long-term potentiation (LTP) associated with increased
IL-1β expression [52,53]. Decreased IL-10 production and
activity in the brain has been previously shown to increase
IL-1β expression [54-56]. It is then plausible that IL-10 in-
duction acts as a negative feedback on pro-inflammatorycytokines IL-1β and TNF-α in the hypothalamus and the
hippocampus, but not in the amygdala and the pre-
frontal cortex of PND14-LPS-treated mice.
PND14-LPS administration has a significant im-
pact on emotional behavior both at adolescence and
adulthood.
The latency to consume food placed in the center of the
arena in the NSFT was used as a behavioral measure for
anxiety in adolescent (PND30) or adult (PND90) mice.
LPS-treated PND14 mice presented an increased latency
in the NSFT at adolescence but not adulthood, indicating
a higher level of anxiety-like behaviors in the PND14-LPS
adolescent mice compared to the control. These differ-
ences could not be attributed to altered locomotor activity
since the mice showed no difference in locomotion (data
not shown). We also evaluated depressive-like behavior
at both periods (PND30 and PND90), and we reported
an increased occurrence of immobility in the FST only
in adult LPS-treated PND14 mice, showing a higher
level of depressive-like behaviors. We reported here for
the first time a dichotomic pattern between anxiety-like
and depressive-like symptoms induced by postnatal in-
flammation. Previous studies demonstrated an aversive
effect of endotoxin exposure in early life on anxiety dur-
ing adulthood [57] but not during adolescence [58] and
on depressive-like behaviors [59]. But, these results were
obtained with a neonatal inflammatory event occurring
between PND3 and PND5, which could account for the
discrepancy since it has been shown that the period of
postnatal exposure to LPS impacts the perinatal program-
ming of adult behavior. Indeed, Spencer et al. demon-
strated that there is not a single ‘critical developmental
window’ but that distinct aspects of adult physiology are
affected by challenges at different developmental stages.
One of these critical windows is after PND7 and before
PND28, periods during which a single immune challenge
is able to alter response to a second LPS challenge at
adulthood [60]. PND14 has previously been shown to be a
critical developmental period for the effect of an immune
challenge, by reducing neuroimmune response to LPS in
adulthood in rats as well as in mice [6,60,61]. These stud-
ies described a long-lasting altered innate immune re-
sponse following a single low-dose immune challenge
applied between PND7 and PND28. Galic et al. also dem-
onstrated in rats that LPS injection at PND14 results in a
greater seizure susceptibility to convulsants that depends
on TNF-α, 6 to 8 weeks after postnatal LPS injection,
indicating that a single LPS injection during a critical
postnatal period causes a long-lasting increase in seiz-
ure susceptibility [62]. Interestingly, it has also been
shown that a neonatal (PND7-8) LPS injection in the
ventral hippocampus elicits persistent increases in IL-1
and IL-2 in the hippocampus, prefrontal cortex and nu-
cleus accumbens that extend into adulthood [63].
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Enhanced inflammatory state is associated with HPA-
axis disturbances in some psychiatric disorders such as
depression [64]. To understand the impact of postnatal
LPS on depressive-like behaviors at adulthood, we inves-
tigated the glucocorticoid pathway in two structures im-
plicated in mood and cognitive behaviors: the prefrontal
cortex and the hippocampus. Even if PND-14 LPS injec-
tion did not impair the basal levels of corticosterone at
adulthood, it induced a decrease in the phosphorylation
of GR in the prefrontal cortex but no change in the
hippocampus. Several studies demonstrated that certain
subsets of depression could be due to glucocorticoid
resistance associated with impairment of GR function
[65,66]. The GR knockdown confined to the infralimbic
prefrontal cortex caused acute stress hyper-responsiveness,
sensitization of stress responses after chronic variable
stress, and depression-like behavior [67]. Anacker et al. re-
cently showed that the antidepressant-induced changes in
neurogenesis are dependent on the GR [68]. Specifically,
they showed that a selective serotonin reuptake inhibitor
increases neuronal differentiation and promotes neuronal
maturation of human hippocampal progenitor cells via a
GR-dependent mechanism that is associated with an in-
crease of GR phosphorylation. Cytokines and their down-
stream signaling molecules can influence the expression
and activity of various factors that regulate local gluco-
corticoid bioavailability and GR function [69]. As demon-
strated in the current study, the inflammatory response
to postnatal LPS was structure-dependent, and this modu-
lation of inflammation between prefrontal cortex and
hippocampus could explain the difference observed in GR
phosphorylation. Indeed studies on the effects of cytokines
on GR function have consistently demonstrated that a var-
iety of cytokines can inhibit GR signaling as reflected by
decreased GR translocation in the nucleus and decreased
activation of relevant GR-inducible enzymes or reporter
gene constructs [70].
A second hit of LPS at adulthood in PND14-LPS ani-
mals induces alterations in hippocampal-dependent
memory and neurogenesis.
It has been shown that the developing hippocampus is
vulnerable to an early-life inflammation, since a single
neonatal infection can affect cognitive processes such as
learning and memory in adulthood [8]. In our context, a
single PND14-LPS injection did not impact spatial work-
ing memory at adolescence and adulthood. But there are
two potential mechanisms by which a neonatal inflamma-
tion might influence adult neural function and associated
learning and memory [32]. Early life immune activation
could permanently damage or disrupt the development
of neural pathways important for learning and memory
within the hippocampus, or alternatively, early-life immuneactivation could reprogram immune function, thereby
negatively affecting how the adult immune system re-
sponds to a subsequent immune challenge via either
prolonged or exaggerated pro-inflammatory cytokine pro-
duction or decreased anti-inflammatory regulation. In this
latter case, abnormal levels of cytokines and chemokines
would indirectly impair the neural processes important for
learning and memory. It appears to be difficult to define
a sensitive period for the long-term cognitive effects of
early-life inflammation [32]. In our study, an immune
challenge at PND14 affects immune function and HPA
axis modulation, sensitizing the system to a second im-
mune challenge at adulthood. Adult mice were challenged
with a second LPS injection at PND90. Twenty-four hours
after this second challenge, animals displayed spatial work-
ing memory deficit.
This alteration of cognitive ability in animals receiving
both juvenile and adult LPS injection was associated to a
decrease in the number of DCX-positive cells in the den-
tate gyrus. In adult, LPS has been reported to diminish
neurogenesis in the dentate gyrus of mammalian brain via
the activation of microglial cells [71-73]. Here, we ob-
served an increase in CCL2 chemokine levels in animals
receiving both juvenile and adult LPS injection (P = 0.06),
but no modulation of other peripheral cytokines (IL-6,
IL-1β, TNF-α and IFN-γ). Increasing peripheral CCL2
chemokine levels in vivo in young mice decreased adult
neurogenesis [74]. Many chemokines have a demonstrated
impact on microglial migration and neural development of
the healthy brain. CCL2 level is associated with cog-
nitive decline, as demonstrated in aged mouse [74] and in
Alzheimer patients [46]. In this study, we demonstrated
that a double-hit challenge with LPS induced alterations of
cognitive ability associated with a decrease in hippocampal
neurogenesis and a modulation of HPA activity.
In conclusion, our data suggest that a PND14 immune
challenge induces anxiety-like and depressive-like symp-
toms throughout life. This is accompanied by a change
in GR activation in the prefrontal cortex, a structure in-
volved in the regulation of mood and emotional behaviors.
This postnatal inflammation seems to induce a ‘perinatal
programming,’ in which the immune system could be ap-
proved. In this context, at adulthood, a second inflamma-
tory event induced cognitive impairment associated with a
decrease in hippocampus neurogenesis and a modulation
of chemokine production. These findings may provide
keys to better understand this crucial postnatal period.
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